|
1
|
Lortet-Tieulent J, Ferlay J, Bray F and
Jemal A: International patterns and trends in endometrial cancer
incidence, 1978–2013. J Natl Cancer Inst. 110:354–361. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and
Prevalence Worldwide in 2012 v1.0. IARC CancerBase. No. 11. Lyon:
2013
|
|
3
|
Prat J, Franceschi S, Denny L, Lazcano
Ponce E, Stewart BW and Wild CP: Endometrial cancer. World Cancer
Report 2014. Steward BW and Wild CP: International Agency for
Research on Cancer; Lyon: pp. 465–481. 2014
|
|
4
|
Wallez Y and Huber P: Endothelial adherens
and tight junctions in vascular homeostasis, inflammation and
angiogenesis. Biochim Biophys Acta. 1778:794–809. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Halbleib JM and Nelson WJ: Cadherins in
development: Cell adhesion, sorting, and tissue morphogenesis.
Genes Dev. 20:3199–3214. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Roy F: Beyond E-cadherin: Roles of
other cadherin superfamily members in cancer. Nat Rev Cancer.
14:121–134. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pal M, Bhattacharya S, Kalyan G and Hazra
S: Cadherin profiling for therapeutic interventions in epithelial
mesenchymal transition (EMT) and tumorigenesis. Exp Cell Res.
368:137–146. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Son H and Moon A: Epithelial-mesenchymal
transition and cell invasion. Toxicol Res. 26:245–252. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oda H, Tsukita S and Takeichi M: Dynamic
behavior of the cadherin-based cell-cell adhesion system during
Drosophila gastrulation. Dev Biol. 203:435–450. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rosivatz E, Becker I, Specht K, Fricke E,
Luber B, Busch R, Höfler H and Becker KF: Differential expression
of the epithelial-mesenchymal transition regulators snail, SIP1,
and twist in gastric cancer. Am J Pathol. 161:1881–1891. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wheelock MJ, Shintani Y, Maeda M, Fukumoto
Y and Johnson KR: Cadherin switching. J Cell Sci. 121:727–735.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gravdal K, Halvorsen OJ, Haukaas SA and
Akslen LA: A switch from E-cadherin to N-cadherin expression
indicates epithelial to mesenchymal transition and is of strong and
independent importance for the progress of prostate cancer. Clin
Cancer Res. 13:7003–7011. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nieman MT, Prudoff RS, Johnson KR and
Wheelock MJ: N-cadherin promotes motility in human breast cancer
cells regardless of their E-cadherin expression. J Cell Biol.
147:631–644. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li G, Satyamoorthy K and Herlyn M:
N-cadherin-mediated intercellular interactions promote survival and
migration of melanoma cells. Cancer Res. 61:3819–3825.
2001.PubMed/NCBI
|
|
15
|
Taniuchi K, Nakagawa H, Hosokawa M,
Nakamura T, Eguchi H, Ohigashi H, Ishikawa O, Katagiri T and
Nakamura Y: Overexpressed P-cadherin/CDH3 promotes motility of
pancreatic cancer cells by interacting with p120ctn and activating
rho-family GTPases. Cancer Res. 65:3092–3099. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shimoyama Y and Hirohashi S: Expression of
E- and P-cadherin in gastric carcinomas. Cancer Res. 51:2185–2192.
1991.PubMed/NCBI
|
|
17
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahmed AR and Muhammad EM: E-cadherin and
CD10 expression in atypical hyperplastic and malignant endometrial
lesions. J Egypt Natl Canc Inst. 26:211–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Carico E, Atlante M, Giarnieri E, Raffa S,
Bucci B, Giovagnoli MR and Vecchione A: E-cadherin and
alpha-catenin expression in normal, hyperplastic and neoplastic
endometrium. Anticancer Res. 30:4993–4997. 2010.PubMed/NCBI
|
|
20
|
Xie X, Zheng X, Wang J and Chen L:
Clinical significance of Twist, E-cadherin, and N-cadherin protein
expression in endometrioid adenocarcinoma. J Cancer Res Ther.
13:817–822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nguyen HP, Xiao L, Deane JA, Tan KS,
Cousins FL, Masuda H, Sprung CN, Rosamilia A and Gargett CE:
N-cadherin identifies human endometrial epithelial progenitor cells
by in vitro stem cell assays. Hum Reprod. 32:2254–2268. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Veatch AL, Carson LF and Ramakrishnan S:
Differential expression of the cell-cell adhesion molecule
E-cadherin in ascites and solid human ovarian tumor cells. Int J
Cancer. 58:393–399. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Risinger JI, Berchuck A, Kohler MF and
Boyd J: Mutations of the E-cadherin gene in human gynecologic
cancers. Nat Genet. 7:98–102. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moreno-Bueno G, Hardisson D, Sarrió D,
Sánchez C, Cassia R, Prat J, Herman JG, Esteller M, Matías-Guiu X
and Palacios J: Abnormalities of E- and P-cadherin and catenin
(beta-, gamma-catenin, and p120ctn) expression in endometrial
cancer and endometrial atypical hyperplasia. J Pathol. 199:471–478.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koyuncuoglu M, Okyay E, Saatli B, Olgan S,
Akin M and Saygili U: Tumor budding and E-cadherin expression in
endometrial carcinoma: Are they prognostic factors in endometrial
cancer? Gynecol Oncol. 125:208–213. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee SJ, Choi SY, Kim WJ, Ji M, Lee TG, Son
BR, Yoon SM, Sung R, Lee EJ, Youn SJ and Park SM: Combined aberrant
expression of E-cadherin and S100A4, but not β-catenin is
associated with disease-free survival and overall survival in
colorectal cancer patients. Diagn Pathol. 8:992013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karamitopoulou E, Zlobec I, Panayiotides
I, Patsouris ES, Peros G, Rallis G, Lapas C, Karakitsos P,
Terracciano LM and Lugli A: Systematic analysis of proteins from
different signaling pathways in the tumor center and the invasive
front of colorectal cancer. Hum Pathol. 42:1888–1896. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng X, Du XL and Jiang T: Prognostic
significance of reduced immunohistochemical expression of
E-cadherin in endometrial cancer-results of a meta-analysis. Int J
Clin Exp Med. 8:18689–18696. 2015.PubMed/NCBI
|
|
29
|
Piura B, Rabinovich A, Aizenberg N and
Wolfson M: Cadherins in malignancies of the female genital tract.
Harefuah. 144:261–265, 303, 302. 2005.(In Hebrew). PubMed/NCBI
|
|
30
|
Stefansson IM, Salvesen HB and Akslen LA:
Prognostic impact of alterations in P-cadherin expression and
related cell adhesion markers in endometrial cancer. J Clin Oncol.
22:1242–1252. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singh M, Darcy KM, Brady WE, Clubwala R,
Weber Z, Rittenbach JV, Akalin A, Whitney CW, Zaino R, Ramirez NC
and Leslie KK: Cadherins, catenins and cell cycle regulators:
Impact on survival in a gynecologic oncology group phase II
endometrial cancer trial. Gynecol Oncol. 123:320–328. 2011.
View Article : Google Scholar : PubMed/NCBI
|
